Annual Cash & Cash Equivalents
$2.86 M
+$845.00 K+41.91%
December 31, 2023
Summary
- As of February 24, 2025, GLMD annual cash & cash equivalents is $2.86 million, with the most recent change of +$845.00 thousand (+41.91%) on December 31, 2023.
- During the last 3 years, GLMD annual cash & cash equivalents has fallen by -$4.09 million (-58.82%).
- GLMD annual cash & cash equivalents is now -88.16% below its all-time high of $24.16 million, reached on December 31, 2018.
Performance
GLMD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$9.72 M
+$7.89 M+429.34%
September 30, 2024
Summary
- As of February 24, 2025, GLMD quarterly cash and cash equivalents is $9.72 million, with the most recent change of +$7.89 million (+429.34%) on September 30, 2024.
- Over the past year, GLMD quarterly cash and cash equivalents has stayed the same.
- GLMD quarterly cash and cash equivalents is now -75.55% below its all-time high of $39.77 million, reached on March 31, 2014.
Performance
GLMD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GLMD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.9% | 0.0% |
| 3 y3 years | -58.8% | 0.0% |
| 5 y5 years | -88.2% | 0.0% |
GLMD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.8% | +41.9% | at high | +863.7% |
| 5 y | 5-year | -82.0% | +41.9% | -41.6% | +863.7% |
| alltime | all time | -88.2% | +1988.3% | -75.5% | +6997.8% |
Galmed Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.72 M(+429.3%) |
| Jun 2024 | - | $1.84 M(+25.6%) |
| Mar 2024 | - | $1.46 M(-48.9%) |
| Dec 2023 | $2.86 M(+41.9%) | $2.86 M(+93.0%) |
| Sep 2023 | - | $1.48 M(+46.9%) |
| Jun 2023 | - | $1.01 M(-39.7%) |
| Mar 2023 | - | $1.67 M(-17.1%) |
| Dec 2022 | $2.02 M(-30.1%) | $2.02 M(-50.4%) |
| Sep 2022 | - | $4.06 M(+105.1%) |
| Jun 2022 | - | $1.98 M(-47.1%) |
| Mar 2022 | - | $3.74 M(+29.7%) |
| Dec 2021 | $2.88 M(-58.5%) | $2.88 M(-17.4%) |
| Sep 2021 | - | $3.49 M(-56.0%) |
| Jun 2021 | - | $7.92 M(-40.8%) |
| Mar 2021 | - | $13.38 M(+92.7%) |
| Dec 2020 | $6.95 M(-56.4%) | $6.95 M(-58.3%) |
| Sep 2020 | - | $16.65 M(+199.8%) |
| Jun 2020 | - | $5.55 M(-58.3%) |
| Mar 2020 | - | $13.32 M(-16.4%) |
| Dec 2019 | $15.93 M | $15.93 M(-12.9%) |
| Sep 2019 | - | $18.29 M(-29.0%) |
| Jun 2019 | - | $25.78 M(-31.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $37.34 M(+54.6%) |
| Dec 2018 | $24.16 M(+85.5%) | $24.16 M(-7.0%) |
| Sep 2018 | - | $25.98 M(+322.4%) |
| Jun 2018 | - | $6.15 M(+133.8%) |
| Mar 2018 | - | $2.63 M(-79.8%) |
| Dec 2017 | $13.02 M(+320.4%) | $13.02 M(+398.1%) |
| Sep 2017 | - | $2.61 M(+49.6%) |
| Jun 2017 | - | $1.75 M(+5.2%) |
| Mar 2017 | - | $1.66 M(-46.4%) |
| Dec 2016 | $3.10 M(-25.5%) | $3.10 M(-56.0%) |
| Sep 2016 | - | $7.04 M(+138.8%) |
| Jun 2016 | - | $2.95 M(-4.5%) |
| Mar 2016 | - | $3.08 M(-25.8%) |
| Dec 2015 | $4.16 M(-82.5%) | $4.16 M(-6.9%) |
| Sep 2015 | - | $4.46 M(-39.1%) |
| Jun 2015 | - | $7.32 M(+213.0%) |
| Mar 2015 | - | $2.34 M(-90.1%) |
| Dec 2014 | $23.74 M(>+9900.0%) | $23.74 M(-32.8%) |
| Sep 2014 | - | $35.34 M(-5.5%) |
| Jun 2014 | - | $37.40 M(-6.0%) |
| Mar 2014 | - | $39.77 M(>+9900.0%) |
| Dec 2013 | $137.00 K(-80.9%) | $137.00 K |
| Dec 2012 | $718.00 K | - |
FAQ
- What is Galmed Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Galmed Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Galmed Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of GLMD is $2.86 M
What is the all time high annual cash & cash equivalents for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual cash & cash equivalents is $24.16 M
What is Galmed Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, GLMD annual cash & cash equivalents has changed by +$845.00 K (+41.91%)
What is Galmed Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GLMD is $9.72 M
What is the all time high quarterly cash and cash equivalents for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly cash and cash equivalents is $39.77 M
What is Galmed Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, GLMD quarterly cash and cash equivalents has changed by $0.00 (0.00%)